{"transactions":[{"id":1281309,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83544,"kind":"person","name":"Brown Gemma","position":1,"cik":"0001947293","reported_name":"Brown Gemma","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2025-02-05T21:24:43.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":160000,"derivative":{"exercise_price":1,"expiration_date":"2035-02-03","underlying":"Ordinary Shares","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001828185-25-000012","document":"wk-form4_1738790675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000182818525000012/wk-form4_1738790675.xml","form_type":"4"}},{"id":1686792,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83544,"kind":"person","name":"Brown Gemma","position":1,"cik":"0001947293","reported_name":"Brown Gemma","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2024-01-04T13:52:44.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":193000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":193000,"derivative":{"exercise_price":3.7,"expiration_date":"2034-01-02","underlying":"Ordinary Shares","underlying_shares":193000},"source":{"system":"sec-edgar","filing":"0001104659-24-001164","document":"tm241766-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000110465924001164/tm241766-1_4seq1.xml","form_type":"4"}},{"id":1995139,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83544,"kind":"person","name":"Brown Gemma","position":1,"cik":"0001947293","reported_name":"Brown Gemma","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-02-23T21:52:13.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":33100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":33100,"derivative":{"exercise_price":2.4,"expiration_date":"2033-01-03","underlying":"Ordinary Shares","underlying_shares":33100},"source":{"system":"sec-edgar","filing":"0001104659-23-024799","document":"tm237643-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000110465923024799/tm237643-1_4seq1.xml","form_type":"4"}},{"id":2149752,"issuer":{"id":9597,"kind":"organization","name":"Barinthus Biotherapeutics plc.","symbol":"BRNS"},"owners":[{"id":83544,"kind":"person","name":"Brown Gemma","position":1,"cik":"0001947293","reported_name":"Brown Gemma","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-09-28T20:05:16.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":334000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on September 15, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":334000,"derivative":{"exercise_price":3.07,"expiration_date":"2032-09-26","underlying":"Ordinary Shares","underlying_shares":334000},"source":{"system":"sec-edgar","filing":"0001104659-22-103706","document":"tm2226822-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828185/000110465922103706/tm2226822-1_4seq1.xml","form_type":"4"}}]}